Recombination breakpoints Family Inheritance Me vs. my brother My dad (my Y)Mom’s dad (uncle’s...

Post on 17-Jan-2016

215 views 0 download

Tags:

Transcript of Recombination breakpoints Family Inheritance Me vs. my brother My dad (my Y)Mom’s dad (uncle’s...

Recombination breakpointsFa

mily

Inhe

ritan

ce

Me vs. my brother

My dad (my Y) Mom’s dad(uncle’s Y)

Hum

an a

nces

try

Dis

ease

risk

Genomics: Regions mechanisms drugs Systems: genes combinations pathways

What is possible with personal genotyping/sequencing

Dad’s mom (his X) (my X)

Challenge: interpreting disease-associated variants

CATGACTGCATGCCTG

Disease-associated

variant (SNP/CNV/…)

Gene annotation

(Coding, 5’/3’UTR, RNAs) Evolutionary signatures

Non-coding annotation

Chromatin signatures

Roles in gene/chromatin regulation

Activator/repressor signatures

Other evidence of function

Signatures of selection (sp/pop)

Ability to predict causal effect of every nucleotide mutation in context• The regulators: Transcription factors, microRNAs, sequence specificities• The regions: enhancers, promoters, and their tissue-specificity• The targets: regulators enhancers/promoters motifs target genes• The grammars: Interplay of multiple TFs prediction of gene expression

The parts list = Building blocks of gene regulatory networks

Requires: Systematic understanding of human genome

Evolutionary signatures reveal genes, RNAs, motifsCompare 29 mammals

Protein-coding Non-coding

MicroRNA

RNA structure

Regulatory motifs

Increased conservation pinpoints functional regions

Distinct patterns of changedistinguish different functions

Mutations in conserved regionsmore likely disease-associated

Disease SNP disrupts a conservedregulatory motif disrupts binding

X

Chromatin signatures reveal regulatory regions and networks

2. Histonemodifications

3. DNA accessibility

1. DNA methylation

Epigenomic maps

Correlated activity: predict links

xx

• Disease-associated SNPs enriched for enhancers in relevant cell types• E.g. lupus SNP in GM enhancer disrupts Ets1 predicted activator

Revisiting disease- associated variants